Ondine to present Health Economic Data at ICPIC

Summary by AI BETAClose X

Ondine Biomedical Inc. will present health economic data on its Steriwave nasal photodisinfection at the 12th International Conference on Prevention & Infection Control in Geneva. A health economic analysis by the York Health Economics Consortium shows Steriwave significantly reduces costs linked to surgical site infections (SSIs). Research indicates Steriwave improves patient outcomes and delivers substantial net savings by preventing SSIs in major surgeries. The Steriwave treatment involves applying a photosensitive agent to each nostril with a nasal swab, followed by illumination with a specific wavelength of red light for five minutes.

Disclaimer*

UK 100

Latest directors dealings